Phoenix Biotech Acquisition (PBAXW) Competitors $0.02 +0.01 (+120.48%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends PBAXW vs. AVHIU, AVHIW, ANSCU, ANSCW, AITRU, AFJKU, AIMBU, AIMAW, AIMAU, and ALCYUShould you be buying Phoenix Biotech Acquisition stock or one of its competitors? The main competitors of Phoenix Biotech Acquisition include Achari Ventures Holdings Corp. I (AVHIU), Achari Ventures Holdings Corp. I (AVHIW), Agriculture & Natural Solutions Acquisition (ANSCU), Agriculture & Natural Solutions Acquisition (ANSCW), AI Transportation Acquisition (AITRU), Aimei Health Technology (AFJKU), Aimfinity Investment Corp. I (AIMBU), Aimfinity Investment Corp. I (AIMAW), Aimfinity Investment Corp. I (AIMAU), and Alchemy Investments Acquisition Corp 1 (ALCYU). These companies are all part of the "shell companies" industry. Phoenix Biotech Acquisition vs. Achari Ventures Holdings Corp. I Achari Ventures Holdings Corp. I Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition AI Transportation Acquisition Aimei Health Technology Aimfinity Investment Corp. I Aimfinity Investment Corp. I Aimfinity Investment Corp. I Alchemy Investments Acquisition Corp 1 Achari Ventures Holdings Corp. I (NASDAQ:AVHIU) and Phoenix Biotech Acquisition (NASDAQ:PBAXW) are both financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership. Which has preferable earnings and valuation, AVHIU or PBAXW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAchari Ventures Holdings Corp. IN/AN/AN/AN/AN/APhoenix Biotech AcquisitionN/AN/AN/AN/AN/A Is AVHIU or PBAXW more profitable? Company Net Margins Return on Equity Return on Assets Achari Ventures Holdings Corp. IN/A N/A N/A Phoenix Biotech Acquisition N/A N/A N/A Does the media favor AVHIU or PBAXW? In the previous week, Achari Ventures Holdings Corp. I's average media sentiment score of 0.00 equaled Phoenix Biotech Acquisition'saverage media sentiment score. Company Overall Sentiment Achari Ventures Holdings Corp. I Neutral Phoenix Biotech Acquisition Neutral Does the MarketBeat Community prefer AVHIU or PBAXW? Achari Ventures Holdings Corp. I and Phoenix Biotech Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAchari Ventures Holdings Corp. IN/AN/APhoenix Biotech AcquisitionN/AN/A SummaryAchari Ventures Holdings Corp. I and Phoenix Biotech Acquisition tied by winning 0 of the 0 factors compared between the two stocks. Ad Behind the MarketsDylan Jovine's #1 Retirement Play for 2024Register: My First LIVE Event in 5 Years! On Tuesday, November 19th, I'm breaking my "no webinars" rule and going LIVE at 8:00pm Eastern. You won't want to miss this event. I'm releasing my No. 1 Retirement Play in 2024. It has nothing to do with regular stocks, options, cryptos or any investment fads.Click here now to register for "Our #1 Takeover Target for November" event. Get Phoenix Biotech Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PBAXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBAXW vs. The Competition Export to ExcelMetricPhoenix Biotech AcquisitionShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$47.30M$3.28B$8.69BDividend YieldN/A5.29%4.59%4.05%P/E RatioN/A32.17427.3215.96Price / SalesN/A967.353,392.9090.87Price / CashN/A91.0348.6436.41Price / BookN/A4.441.485.85Net IncomeN/A-$3.19M$397.02M$225.13M7 Day PerformanceN/A1.01%-0.11%-1.18%1 Month PerformanceN/A2.86%0.98%3.33%1 Year PerformanceN/A0.74%16.21%24.34% Phoenix Biotech Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBAXWPhoenix Biotech AcquisitionN/A$0.02+120.5%N/A-75.3%$0.00N/A0.00N/AGap UpHigh Trading VolumeAVHIUAchari Ventures Holdings Corp. IN/A$10.00flatN/AN/A$0.00N/A0.003AVHIWAchari Ventures Holdings Corp. IN/A$0.01flatN/AN/A$0.00N/A0.003ANSCUAgriculture & Natural Solutions AcquisitionN/A$10.53flatN/AN/A$0.00N/A0.00N/APositive NewsANSCWAgriculture & Natural Solutions AcquisitionN/A$0.30+7.1%N/AN/A$0.00N/A0.00N/APositive NewsGap UpAITRUAI Transportation AcquisitionN/A$10.85+1.4%N/A+6.8%$0.00N/A0.00N/AAFJKUAimei Health TechnologyN/A$10.75flatN/AN/A$0.00N/A0.00N/APositive NewsAIMBUAimfinity Investment Corp. IN/A$11.65+0.1%N/A+7.8%$0.00N/A0.002Positive NewsAIMAWAimfinity Investment Corp. IN/A$0.01flatN/AN/A$0.00N/A0.00N/APositive NewsAIMAUAimfinity Investment Corp. IN/A$11.60flatN/A+7.4%$0.00N/A0.00N/APositive NewsALCYUAlchemy Investments Acquisition Corp 1N/A$12.10+0.7%N/AN/A$0.00N/A0.00N/APositive NewsGap Down Related Companies and Tools Related Companies AVHIU Competitors AVHIW Competitors ANSCU Competitors ANSCW Competitors AITRU Competitors AFJKU Competitors AIMBU Competitors AIMAW Competitors AIMAU Competitors ALCYU Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PBAXW) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this BEFORE November 19th.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phoenix Biotech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phoenix Biotech Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
